Gonorrhea has defeated nearly every antibiotic medicine has aimed at it, from sulfa and penicillin to tetracycline, fluoroquinolones, and azithromycin, until only the injectable ceftriaxone remains. There was never an American cure to celebrate. What the federal government built instead is a system for watching: the CDC's Gonococcal Isolate Surveillance Project, which tracks resistance and rewrites treatment guidelines as each drug fails.
Ceftriaxone still works for the overwhelming majority of U.S. cases, so claims of imminent untreatability overstate the risk. Resistance percentages shift year to year, and new drugs in development remain hopeful rather than settled.